|
 
- 积分
- 460
- 威望
- 460
- 包包
- 1467
|

1.Bastian, P. J., J. Ellinger, et al. (2004). "GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?" Eur J Med Res 9(11): 523-527.' h" f& @; Q/ o3 |1 B
2.Bastian, P. J., M. Nakayama, et al. (2004). "[GSTP1 CpG island hypermethylation as a molecular marker of prostate cancer]." Urologe A 43(5): 573-579.4 I) p( }1 z. T) C K/ o$ a" Z" H
3.Bastian, P. J., G. S. Palapattu, et al. (2008). "CpG island hypermethylation profile in the serum of men with clinically localized and hormone refractory metastatic prostate cancer." J Urol 179(2): 529-534; discussion 534-525.8 w! T6 s6 C0 @" @' c
4.Bernardini, S., R. Miano, et al. (2004). "Hypermethylation of the CpG islands in the promoter region of the GSTP1 gene in prostate cancer: a useful diagnostic and prognostic marker?" Clin Chim Acta 350(1-2): 181-188.
! g* _' v* r8 m0 O5.Bryzgunova, O. E., E. S. Morozkin, et al. (2008). "Methylation-specific sequencing of GSTP1 gene promoter in circulating/extracellular DNA from blood and urine of healthy donors and prostate cancer patients." Ann N Y Acad Sci 1137: 222-225.
( T9 N0 P0 W; u5 J6.Chu, D. C., C. K. Chuang, et al. (2002). "The use of real-time quantitative polymerase chain reaction to detect hypermethylation of the CpG islands in the promoter region flanking the GSTP1 gene to diagnose prostate carcinoma." J Urol 167(4): 1854-1858.
, C; Q' [; c* ?% b& U! I7.Chuang, C. K., D. C. Chu, et al. (2007). "Hypermethylation of the CpG islands in the promoter region flanking GSTP1 gene is a potential plasma DNA biomarker for detecting prostate carcinoma." Cancer Detect Prev 31(1): 59-63.; n7 c2 [; H3 {' K- d$ ~( E7 k
8.Crocitto, L. E., D. Korns, et al. (2004). "Prostate cancer molecular markers GSTP1 and hTERT in expressed prostatic secretions as predictors of biopsy results." Urology 64(4): 821-825.* K4 b* D0 q4 M, G1 H
9.De Marzo, A. M., A. K. Meeker, et al. (2003). "Human prostate cancer precursors and pathobiology." Urology 62(5 Suppl 1): 55-62.
+ E9 i6 r# D" {5 y# w! U: w10.Devaney, J., C. Stirzaker, et al. (2011). "Epigenetic deregulation across chromosome 2q14.2 differentiates normal from prostate cancer and provides 11.a regional panel of novel DNA methylation cancer biomarkers." Cancer Epidemiol Biomarkers Prev 20(1): 148-159.
7 ?+ O6 Y# `8 M# l/ V4 M" _' s* S12.Eilers, T., S. Machtens, et al. (2007). "Prospective diagnostic efficiency of biopsy washing DNA GSTP1 island hypermethylation for detection of adenocarcinoma of the prostate." Prostate 67(7): 757-763.
% x6 K. Q. j* B; k3 X, [5 i- N13.Goessl, C., M. Muller, et al. (2001). "DNA-based detection of prostate cancer in blood, urine, and ejaculates." Ann N Y Acad Sci 945: 51-58.
1 H& V8 ~; ], c& h5 Z1 O# l( e- [14.Goessl, C., M. Muller, et al. (2002). "Methylation-specific PCR for detection of neoplastic DNA in biopsy washings." J Pathol 196(3): 331-334.
8 w( |- f! J- ~! @# U) m* I9 M15.Goessl, C., M. Muller, et al. (2001). "DNA-based detection of prostate cancer in urine after prostatic massage." Urology 58(3): 335-338.2 ] R( t2 r. K% V0 M
16.Gonzalgo, M. L., M. Nakayama, et al. (2004). "Detection of GSTP1 methylation in prostatic secretions using combinatorial MSP analysis." Urology 63(2): 414-418.# ?# }6 C+ o- C1 p
17.Harden, S. V., Z. Guo, et al. (2003). "Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma." J Urol 169(3): 1138-1142.
! @) E) u3 m; P# b* P8 ~小弟学校条件比较差,请高手帮助。非恶意一次要求这么多文献求助。; }2 l! t p# m t. C
Harden, S. V., H. Sanderson, et al. (2003). "Quantitative GSTP1 methylation and the detection of prostate adenocarcinoma in sextant biopsies." J Natl Cancer Inst 95(21): 1634-1637.
1 T' ^$ {( b% Y3 ?- j' p |
|